2 unchanged sentences
Certificate of Incorporation (incorporated by reference to Exhibit 2.1 of Form DOS filed with the SEC on August 19, 2016).
−Removed: Amended and Restated Bylaws.
+Added: Certificate of Amendment to the Certificate of Incorporation, filed with the Delaware Secretary of State on June 10, 2016.
+Added: Certificate of Amendment to the Certificate of Incorporation, filed with the Delaware Secretary of State on December 22, 2020.
+Added: Certificate of Amendment to the Certificate of Incorporation, filed with the Delaware Secretary of State on October 27, 2023 (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed with the SEC on October 30, 2023).
Certificate of Designation of Alzamend Neuro, Inc.
Series A Convertible Preferred Stock, dated May 30, 2016 (incorporated by reference to Exhibit 2.3 of Form 1-A/A filed with the SEC on February 4, 2020).
−Removed: Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC18110 with the University of South Florida Research Foundation, Inc., dated June 8, 2023 (incorporated by reference to Exhibit 10.16 of the Annual Report on Form 10-K filed with the SEC on July 27, 2023).
−Removed: Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC18111 with the University of South Florida Research Foundation, Inc., dated June 8, 2023 (incorporated by reference to Exhibit 10.17 of the Annual Report on Form 10-K filed with the SEC on July 27, 2023).
+Added: Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 of the registration statement on Form S-1 filed with the SEC on May 10, 2021).
+Added: At-The-Market Issuance Sales Agreement, dated September 8, 2023, with Ascendiant Capital Markets, LLC (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed with the SEC on September 8, 2023).
+Added: Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC16118 with University of South Florida Research Foundation, Inc., dated December 11, 2023.
Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
15 unchanged sentences
extent specifically incorporated by reference into such filing.
−Removed: Pursuant to the requirements of Section 13 or
−Removed: 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
+Added: Pursuant to the requirements of Section
+Added: 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
ALZAMEND NEURO, INC.
−Removed: September 13, 2023
+Added: December 15, 2023
/s/ Stephan Jackman
1 unchanged sentence
Chief Executive Officer (principal executive officer)
−Removed: September 13, 2023
+Added: December 15, 2023
Chief Financial Officer (principal financial and accounting officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.